All Videos Channels
  1. Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs

    Reviva: Developing Next-Generation Therapies for Diseases with Significant Unmet Needs

    3
  2. BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

    BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

    6
  6. September 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from Schizophrenia

    September 2023 - Learn How This Company's Phase 3 Drug Could Improve the Mental Health of Patients Suffering from Schizophrenia

    299
  7. Desperately seeking Medical Expertise (samples.. )

    Desperately seeking Medical Expertise (samples.. )

    24
  8. Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    3
    0
    6
  10. Peptilogics founder Jonathan Steckbeck (Peter Thiel-backed BioTech) Full Interview

    Peptilogics founder Jonathan Steckbeck (Peter Thiel-backed BioTech) Full Interview

    6
  11. Reviva: Providing a Major Breakthrough for Mental Health and Schizophrenia

    Reviva: Providing a Major Breakthrough for Mental Health and Schizophrenia

    8
  12. Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial

    Reviva: Announcing Completion of Enrollment of Pivotal Phase 3 Trial

    7
  13. BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease

    BioVie(NASDAQ:BIVI): Advancing Transformative Therapies for Neurodegeneration and Liver Disease

    1
  14. Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

    Engineering Proteins To Enhance Medicine With GRO Biosciences CEO Daniel J. Mandell

    5
  15. In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More

    In the Spotlight: BioVie's (NASDAQ: BIVI) Quest to Tackle Alzheimer's, Parkinson's, and More

    2
  16. Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    2
  17. Learn How This Company is Revolutionizing Pet Care

    Learn How This Company is Revolutionizing Pet Care

  18. Unicycive Therapeutics: Advancing Breakthroughs in Kidney Disease Therapies

    Unicycive Therapeutics: Advancing Breakthroughs in Kidney Disease Therapies

  19. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    18
  21. Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    12
  22. HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    17
  23. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    5
  24. Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    Reviva: A Beacon of Hope for Those Suffering with Mental Illnesses

    10
  25. Unicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity in Kidney Disease

    Unicycive Therapeutics: Addressing a $2.5 Billion Global Market Opportunity in Kidney Disease

    1